Year: 2020
Type: article
Abstract: The tobacco industry offers various products, including heated tobacco products (HTPs). Philip Morris International's (PMI) "iQOS" has the greatest HTP market share, as well as research on its use and impact. iQOS was released in 2014 and is now in more than 40 countries. The U.S. Food and Drug Administration announced permission for PMI to sell iQOS in the United States in April 2019, and iQOS was launched in October 2019. Decisions pending its modified risk tobacco product (MRTP) application will occur subsequently. The U.S. regulatory efforts regarding iQOS could be informed by examining (a) Philip Morris USA other product marketing efforts and (b) the iQOS market in countries where it is available. This article briefly addresses these two points with extant literature and suggests that future research should address important gaps in what is currently known, including strategic international collaborations and research, which historically has been critical for advancing tobacco control globally.
Source: SAGE Open
Authors: Carla J. Berg, Yael Bar-Zeev, Hagai Levine
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $800
Awards: Market Research to Predict Emerging Tobacco Product Use in Diverse Young Adults, Assessing IQOS Marketing Influences and Consumer Behavior in Israel: Implications for the US, Regulatory Impact on Vape Shops and Young Adults' Use of ENDS, Smoke-free Air Coalitions in Georgia and Armenia: A Community Randomized Trial, Emory-Georgia Clean Air Research & Education (CARE) Program
OpenAlex ID: W3000130902